非甾体抗炎药镇痛作用的临床应用进展

被引:166
作者
邓小虎
机构
[1] 解放军总医院风湿科
关键词
非甾体抗炎药; 镇痛; 临床应用;
D O I
暂无
中图分类号
R971.1 [];
学科分类号
摘要
非甾体抗炎药(non-steroidal anti-inflammatory drugs,NSAIDs)为最常用的镇痛药,目前已知所有的NSAIDs均具有不同程度的不良反应,包括胃肠道和心血管不良反应等,但是各种疼痛治疗指南仍推荐使用。很好的用药策略以及规范地遵从指南有助于减少NSAIDs相关并发症的出现。本文回顾了NSAIDs的作用机制及各种疼痛的临床治疗指南,比较了各种NSAIDs的镇痛效果,总结了NSAIDs的不良反应及防止不良反应的策略及将来的发展。
引用
收藏
页码:1637 / 1642
页数:6
相关论文
共 12 条
[1]
OARSI guidelines for the non-surgical management of knee osteoarthritis[J] T.E. McAlindon;R.R. Bannuru;M.C. Sullivan;N.K. Arden;F. Berenbaum;S.M. Bierma-Zeinstra;G.A. Hawker;Y. Henrotin;D.J. Hunter;H. Kawaguchi;K. Kwoh;S. Lohmander;F. Rannou;E.M. Roos;M. Underwood Osteoarthritis and Cartilage 2014,
[2]
Diclofenac submicron particle capsules demonstrate early and sustained acute pain relief in a phase 3 study in patients following bunionectomy surgery[J] C. Argoff;S. Silberstein;A. Gibofsky;S. Daniels;S. Jensen;C. Young Osteoarthritis and Cartilage 2013,
[3]
Nonsteroidal anti-inflammatory drugs in the treatment of low back pain[J] Samraj;L Kuritzky Journal of Pain Research 2012,
[4]
A turbulent decade for NSAIDs: update on current concepts of classification; epidemiology; comparative efficacy; and toxicity[J] Philip G. Conaghan Rheumatology International 2012,
[5]
Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society[J] S. Holland;S.D. Silberstein;F. Freitag;D.W. Dodick;C. Argoff;E. Ashman Neurology 2012,
[6]
Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective; randomized; multicenter study[J] T.J. Schnitzer;A. Kivitz;H. Frayssinet;B. Duquesroix Osteoarthritis and Cartilage 2010,
[7]
Meta‐Analysis of the Efficacy and Safety of Naproxen Sodium in the Acute Treatment of Migraine[J] Chuthamanee C.Suthisisang;NalineePoolsup;NaetiSuksomboon;VorachartLertpipopmetha;BhakanitTepwitukgid Headache: The Journal of Head and Face Pain 2010,
[8]
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison[J] Loren Laine;Sean P Curtis;Byron Cryer;Amarjot Kaur;Christopher P Cannon The Lancet 2007,
[9]
Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study[J] Gurkirpal Singh;John G. Fort;Jay L. Goldstein;Roger A. Levy;Patrick S. Hanrahan;Alfonso E. Bello;Lilia Andrade-Ortega;Carl Wallemark;Naurang M. Agrawal;Glenn M. Eisen;William F. Stenson;George Triadafilopoulos The American Journal of Medicine 2006,
[10]
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib[J] Roy Fleischmann;Eric Sheldon;José Maldonado-Cocco;Dipen Dutta;Sue Yu;Victor S. Sloan Clinical Rheumatology 2005,